ABBOTT BIORESEARCH

WORCESTER, MA US

1. 20090270402 Novel triazolopyridazines - novel compounds of formula STR00001 wherein the variables are defined as herein 10-29-2009
2. 20090232736 Dual specificity antibodies and methods of making and using 09-17-2009
3. 20090209609 Thienopyrroles and pyrrolothiazoles as new therapeutic agents 08-20-2009
4. 20090202557 Compositions and methods for crystallizing antibody fragments 08-13-2009
5. 20090148513 Compositions and methods for crystallizing antibodies 06-11-2009
6. 20090118298 Octahydropentalene compounds as chemokine receptor antagonists 05-07-2009
7. 20090069288 Novel therapeutic compounds - Disclosed herein are novel compounds of Formula , STR00001 wherein the variables are defined as herein 03-12-2009
8. 20090068172 Compositions and methods comprising binding proteins for adalimumab 03-12-2009
9. 20090029947 Sphingosine-1-phosphate receptor agonist and antagonist compounds 01-29-2009
10. 20080292642 Crystalline anti-human IL-12 antibodies - batch crystallization methods for crystallizing an anti-hIL-12 antibody that allows the production of the 11-27-2008
11. 20080280876 Novel oxadiazole compounds - pharmaceutical compositions containing such compounds and the use of those compounds or compositions as agonists or 11-13-2008
12. 20080255367 Process for the preparation and isolation of the individual stereoisomers of 1-amino, 3-substituted phenylcyclopentane-carboxylates 10-16-2008
13. 20080249305 Novel imidazole based heterocycles - novel imidazopyrazine compounds useful as kinase inhibitors and as such would be useful in treating certain 10-09-2008
14. 20080242862 Novel imidazo based heterocycles - novel imidazopyrazine compounds useful as kinase inhibitors and as such would be useful in treating certain 10-02-2008
15. 20080227704 CXCL13 binding proteins - The present invention encompasses CXCL13 binding proteins 09-18-2008